These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34868073)

  • 21. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC; Monto AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Smith GE; Sun X; Bai Y; Liu YV; Massare MJ; Pearce MB; Belser JA; Maines TR; Creager HM; Glenn GM; Flyer D; Pushko P; Levine MZ; Tumpey TM
    Virology; 2017 Sep; 509():90-97. PubMed ID: 28624679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype.
    Peeters B; de Boer SM; Tjeerdsma G; Moormann R; Koch G
    Vaccine; 2012 Nov; 30(49):7078-83. PubMed ID: 23036502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drift and shape-new insights into human immunity against influenza virus neuraminidase.
    Fox A
    mBio; 2023 Dec; 14(6):e0165423. PubMed ID: 37933976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.
    Wen Z; Ye L; Gao Y; Pan L; Dong K; Bu Z; Compans RW; Yang C
    Antiviral Res; 2009 Dec; 84(3):215-24. PubMed ID: 19772876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs.
    McMahon M; Kirkpatrick E; Stadlbauer D; Strohmeier S; Bouvier NM; Krammer F
    mBio; 2019 May; 10(3):. PubMed ID: 31113896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE; Matthews JT; Kilbourne ED
    Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-neuraminidase immunity in the combat against influenza.
    Zhang X; Ross TM
    Expert Rev Vaccines; 2024; 23(1):474-484. PubMed ID: 38632930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    Zheng A; Sun W; Xiong X; Freyn AW; Peukes J; Strohmeier S; Nachbagauer R; Briggs JAG; Krammer F; Palese P
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.
    Kirkpatrick Roubidoux E; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.
    Gao J; Klenow L; Parsons L; Malik T; Phue JN; Gao Z; Withers SG; Cipollo J; Daniels R; Wan H
    J Virol; 2021 Nov; 95(24):e0116021. PubMed ID: 34613807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.